NKCC1 activity in HFLS and RA-FLS was enhanced by treatment with IL-6, whereas NKCC1 activity of OA-FLS was mildly enhanced with no statistical difference (Figures 3E–H). Here, SLC12A2 is linked to rheumatoid arthritis.